Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing

Tiziano Ingegnere, Francesca Romana Mariotti, Andrea Pelosi, +8

Frontiers in Immunology

Cell TherapyCancer ImmunosurveillanceHuman Nk CellsImmunologyGenetic Engineering +12

A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas

Giulia Regazzo, Irene Terrenato, Manuela Spagnuolo, +9

Journal of Experimental & Clinical Cancer Research

A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes

Silvia Careccia, Sara Mainardi, Andrea Pelosi, +12

Oncogene

Systems BiologyDevelopmental BiologyEngineeringCell DivisionMedicine +13

miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia

Andrea Pelosi, Silvia Careccia, Valentina Lulli, +10

Oncogene

Hematological MalignancyAcute Myeloid LeukemiaHematologyMicrorna DetectionMedicine +3

A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7

Barbara Hopkins, Monica J. S. Nadler, John Skoko, +15

Antioxidants and Redox Signaling

CPTH6, a Thiazole Derivative, Induces Histone Hypoacetylation and Apoptosis in Human Leukemia Cells

Daniela Trisciuoglio, Ylenia Ragazzoni, Andrea Pelosi, +14

Clinical Cancer Research

Gene Expression Profiling in Behcet’s Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy

Antonio Puccetti, Piera Filomena Fiore, Andrea Pelosi, +6

Journal of Immunology Research

ImmunologyImmune RegulationPathologyImmunologic MechanismImmune System +19

Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures

Marzia Dolcino, Andrea Pelosi, Piera Filomena Fiore, +4

Frontiers in Immunology

ImmunologyGenetic EpidemiologyPathologyGene CharacterizationDisease Gene Identification +15

MicroRNA Expression Profiling in Behçet’s Disease

Antonio Puccetti, Andrea Pelosi, Piera Filomena Fiore, +3

Journal of Immunology Research

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56^brightCD16⁻ subset

Irene Veneziani, Claudia Alicata, Andrea Pelosi, +7

Journal for ImmunoTherapy of Cancer